Investigating the effects of Shikonin, Deoxyshikonin and (β,β-dimethylacryl)shikonin on melanoma cell lines

Investigating the effects of Shikonin, Deoxyshikonin and (β,β-dimethylacryl)shikonin on melanoma cell lines
Title:
Investigating the effects of Shikonin, Deoxyshikonin and (β,β-dimethylacryl)shikonin on melanoma cell lines
Other Titles:
Natural Product Communications
Keywords:
Publication Date:
28 April 2020
Citation:
4. Ng JJD, Upton Z, Leavesley D, Chen Fan. Investigating the effects of Shikonin, Deoxyshikonin and (β,β-dimethylacryl)shikonin on melanoma cell lines. Natural Product Comm. 15(4): 1-12. 2020; doi: 10.1177/1934578X20922328.
Abstract:
Melanoma is the most lethal form of various skin cancers and contributes to more than 79% of all skin cancer deaths. Although there are numerous therapies available for melanoma, the high rate of recurrence in melanoma post-therapy remains a challenging issue for both patients and clinicians. Apoptosis is one of the foundations for cancer treatment as deficient apoptosis is one of the most essential reasons for the formation of tumour tissues. Shikonin (SHI), an active component extracted from Lithospermum erythrorhizon , has been broadly demonstrated to possess antitumorigenic property due to its apoptosis-inducing ability in various cancer cell lines. The analogs of SHI, such as deoxyshikonin (DO-SHI) and (β,β-dimethylacryl)shikonin (β,β-SHI), have also been found to possess similar bioactivities. The apoptosis-inducing ability of SHI and its analogs enable them to be potential anticancer therapies. In this study reported herein, we investigated the effects of SHI, DO-SHI, and β,β-SHI on both human (A375) and mouse (B16-F0 and B16-F10) melanoma cell lines. Cell viability was measured using Alamar blue assay, while cell migration was detected using scratch assay. Cell apoptosis was captured using terminal deoxynucleotidyl dUTP nick end labeling and fluorescence activated cell sorting. Signaling pathway activation was detected using Western blotting. Our results revealed that SHI, DO-SHI, and β,β-SHI reduce cell viability, inhibit cell migration, and induce apoptosis in melanoma cell lines. These 3 molecules-induced apoptosis in A375 is regulated via mitogen-activated protein kinase/caspase 3 signaling pathway. In particular, DO-SHI and β,β- SHI induce higher apoptosis rate in A375 and B16-F0 compared to SHI. The data from this study demonstrate that DO-SHI and β,β-SHI offer potential new reagents for managing melanoma.
License type:
http://creativecommons.org/licenses/by-nc/4.0/
Funding Info:
This work was supported by funding from Singapore's Agency for Science, Technology and Research "SPF 2013/004: Skin Biology Basic Research" and the "Wound Care Innovation for the Tropics" IAF-PP/ 2017 (HBMS) H17/01/a0/009.
Description:
ISSN:
1934-578X
Files uploaded: